More answers like this
Grok 4.5Oct 26, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

[1][2]No, the US is not fully prepared for another pandemic or widespread health crisis, though it has improved in specific technical areas since COVID-19. Assessments from government watchdogs, bipartisan commissions, public health organizations, and experts consistently highlight progress alongside persistent, significant gaps in leadership/coordination, sustained funding, workforce, supply chains, equity, public trust, and implementation of lessons learned. Recent policy shifts (as of 2025–2026) appear to have eroded some gains.[3]

Key Improvements Post-COVID

•Stockpiles and countermeasures: The Strategic National Stockpile (SNS) was substantially replenished. Compared to pre-pandemic levels, it has held far more PPE (e.g., reports of 70x N95 respirators, tens of times more gloves/gowns, and more ventilators in the Biden-era assessments). It has supported responses to H5N1, mpox, and other events. Investments expanded domestic manufacturing and BARDA-supported medical countermeasures (vaccines, therapeutics, diagnostics).[4]
•Surveillance and data: Major advances include electronic case reporting expanding from under 200 healthcare facilities pre-COVID to over 45,000–48,000 by 2024; broader syndromic surveillance (over 80% of hospital EDs); wastewater monitoring; and improved genomic sequencing/risk modeling. CDC has created “warm base” lab partnerships for faster testing.[5]
•Coordination structures: Creation of the White House Office of Pandemic Preparedness and Response Policy (OPPR) in 2023 for cross-agency leadership. Updated policies on dual-use research and biosafety. Experience from COVID vaccination campaigns (hundreds of millions of doses), testing distribution, and equity-focused outreach.[4]
•Global Health Security Index: The US ranks #1 overall (score ~83.5/100 in recent data), strong in detection, prevention, and some response capacities relative to other countries (global average much lower).[1]
•State variations and other gains: Some states score high on preparedness indicators (e.g., nurse licensure compacts for surge staffing, accreditations). Investments in community health workers and certain manufacturing.

These build on frameworks like the Pandemic and All-Hazards Preparedness Act (PAHPA) and Public Health Emergency Medical Countermeasures Enterprise (PHEMCE).

Persistent and Critical Gaps

•Leadership, coordination, and implementation: The Government Accountability Office (GAO) has issued hundreds of recommendations related to COVID lessons (428+ to agencies, with ~220 open as of mid-2024). HHS leadership and coordination of public health emergencies remains a high-risk area, with issues in roles/responsibilities, real-time situational awareness networks (required since 2006 but incomplete), supply shortage mitigation plans, and partner collaboration. Many after-action findings from exercises and COVID were not fully addressed.[3][6]
•Funding and sustainability: Chronic underfunding of public health infrastructure. PHEMCE faces multi-billion-dollar shortfalls. Many states cut public health funding post-COVID supplemental funds (14 states in FY2024). SNS and related programs have been repeatedly flagged as under-resourced relative to requirements for CBRN + pandemic threats. Global efforts (e.g., contributions to WHO, Pandemic Fund, USAID-related) faced cuts or freezes.[7][8]
•State and local readiness (TFAH Ready or Not 2025): Only 21 states + DC in the high-performance tier; 16 medium and 13 low. Strengths in some areas (e.g., nurse compact growth, water safety, accreditations), but weaknesses in public health funding stability, paid time off access (aids infection control), flu vaccination rates (~47%, far below 70% goal), avoidable mortality (disparities by race/geography signaling weaker baseline resilience), and lab surge capacity. All states have room to improve.[7]
•Healthcare system capacity: Workforce shortages, hospital/ICU strain risks, supply chain vulnerabilities (though some domestic production gains), and inequities that amplify impacts on vulnerable populations.
•Other issues: Low public trust/misinformation challenges effective response; fragmented federal-state dynamics; gaps in antimicrobial resistance, zoonotic surveillance (e.g., H5N1 bird flu in cattle/poultry with limited human cases but ongoing concerns), and full exercise of plans. The Bipartisan Commission on Biodefense’s 2024 National Blueprint stated the nation “remains dangerously vulnerable,” with fragmented efforts and a need for top-level leadership and sustained “on all the time” posture rather than boom-bust cycles. It warned that failure to act earlier worsened COVID outcomes and that worse events are possible.[9]

Recent Developments (2025–2026)

Under the second Trump administration, reports document staff reductions, program cuts or wind-downs (including certain mRNA/vaccine development projects and biosurveillance), understaffing or temporary emptying of OPPR, withdrawal from WHO, reduced foreign assistance affecting global early-warning systems, and shifts away from some prior playbooks. Experts and former officials have described these as damaging preparedness, with slower or patchwork responses to outbreaks (e.g., Ebola, hantavirus, measles). Public opinion reflects this: only about 35% of Americans believe the US is adequately prepared. ASPR continues operations (e.g., SNS distributions, MCM plans), but overall capacity and expertise appear strained.[10][11]

Bottom Line

On paper and in select capabilities (stockpiles, tech-enabled surveillance, platform technologies like mRNA), the US is stronger than in 2019. It has tools and experience that could enable a faster initial response. However, systemic weaknesses in sustained investment, unified leadership/coordination across federal-state-local levels, workforce resilience, equity, trust, and full follow-through on recommendations mean it is not adequately prepared for a severe, widespread crisis comparable to or worse than COVID-19 (or a novel high-mortality pathogen, bioterror event, or concurrent disasters). Progress has been fragile and uneven; experts from GAO, TFAH, the Biodefense Commission, and others emphasize that more consistent funding, clearer authorities, stronger public health infrastructure, and political will are essential. Preparedness is not binary—it is a continuous process—and current trajectories leave significant vulnerabilities.

Citations (11)

  1. 1ghsindex.orgNot yet classified
    https://ghsindex.org/country/united-states/

    Backs: “[[1]](https://ghsindex.org/country/united-states/)”

  2. 2ipsos.comCompanies
    https://www.ipsos.com/en-us/axios-ipsos-american-health-index

    Backs: “[[2]](https://www.ipsos.com/en-us/axios-ipsos-american-health-index)”

  3. 3gao.govGovernment
    https://www.gao.gov/products/gao-24-107175

    Backs: “Recent policy shifts (as of 2025–2026) appear to have eroded some gains.”

  4. 4archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “Investments expanded domestic manufacturing and BARDA-supported medical countermeasures (vaccines, therapeutics, diagnostics).”

  5. 5cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “CDC has created “warm base” lab partnerships for faster testing.”

  6. 6gao.govGovernment
    https://www.gao.gov/products/gao-23-106829

    Backs: “Many after-action findings from exercises and COVID were not fully addressed.”

  7. 7tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/

    Backs: “Global efforts (e.g., contributions to WHO, Pandemic Fund, USAID-related) faced cuts or freezes.”

  8. 8center-forward.orgNonprofits and think tanks
    https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/

    Backs: “Global efforts (e.g., contributions to WHO, Pandemic Fund, USAID-related) faced cuts or freezes.”

  9. 9biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “It warned that failure to act earlier worsened COVID outcomes and that worse events are possible.”

  10. 10theguardian.comNews and mediaquality 0.75
    https://www.theguardian.com/us-news/2026/may/17/pandemic-preparedness-after-covid

    Backs: “ASPR continues operations (e.g., SNS distributions, MCM plans), but overall capacity and expertise appear strained.”

  11. 11science.orgAcademic
    https://www.science.org/content/article/trump-administration-dismantling-efforts-fight-next-pandemic

    Backs: “ASPR continues operations (e.g., SNS distributions, MCM plans), but overall capacity and expertise appear strained.”